Portfolio

Pending AI

Supercharging drug discovery with quantum-accurate AI.
Up Arrow Icon

Pending AI

→

Leaders
Mark Waller
Mark Waller
Founder and CEO
Investment Team
challenges
Drug discovery is slow, expensive, and constrained by poor datasets and models, limited chemical space and inefficient synthesis pathways—leading to high failure rates and delayed treatments.
solution
Pending AI integrates quantum-accurate AI binding models with the world’s largest proprietary database of >1T molecules and a novel retrosynthesis engine delivering lab-ready synthetic steps for rapid execution.
For founders

Building for the systems that matter? Pitch us.

We back founders turning breakthrough science into category-defining companies.

Submit your pitch
For investors

Invest with Main Sequence

Access Australia's deep tech frontier alongside us.

Investor enquiries